​​Elsevier’s ClinicalKey AI wins third consecutive AI Innovation Award from Medtech Breakthrough Award program​

Elsevier’s ClinicalKey AI has been awarded the MedTech Breakthrough Award for AI Innovation, a program which recognizes the most innovative products in the global digital health market. This is the third consecutive year ClinicalKey AI has won this award since it was launched in February 2024.

ClinicalKey AI is a clinical decision support solution that delivers the latest clinical information at the point of care within the clinical workflow. It combines trusted, evidence-based clinical content with conversational search powered by generative AI and has been recently enhanced with more content, workflow enhancements, and transparency features for confidence and clarity.

In addition to SMART on FHIR integration, new API capabilities allow ClinicalKey AI to be directly added into an organization’s workflow solutions. Accessibility features include native voice-to-text dictation, adult and pediatric toggling for population-focused results and CME credits and MOC for select boards. Clinicians can access subscription resources available at their institution for Elsevier and non-Elsevier content that may be cited in the response through the Link Resolver feature.

Omry Bigger, President of Clinical Solutions at Elsevier said: “It’s a great honor to accept this award from MedTech Breakthrough. Since launching ClinicalKey AI, we’ve made continuous improvements to respond to the needs of our customers. Winning this award reflects the continuous improvements we’ve made to expand the product’s content, reliability and traceability, ensuring clinicians get trusted information quickly when they need it most.”

To expand the evidence-based sources that power AI responses in the tool, ClinicalKey AI has doubled the volume of full-text journal articles and tripled the number of guidelines sets. Society guidelines from multiple specialties have also been incorporated for discipline-specific information, like the American College of Cardiology, the American College of Emergency Physicians, and more.

Steve Johansson, Managing Director at MedTech Breakthrough said “This innovative clinical decision support tool helps transform complexity into clarity. It is vital that AI-powered tools properly support clinicians to provide high-quality patient care and that they are easy to access, provide clear answers, ensure traceability and allow for deeper investigation. ClinicalKey AI helps clinicians navigate complex questions, enhance decision-making at the point of care, and advances safer, more effective patient care across specialties – many congratulations on your third AI Innovation Award win.”

This is the 10^th annual MedTech Breakthrough Awards, conducted by MedTech Breakthroughopens in new tab/window, an independent market intelligence organization that recognizes the most innovative companies, products and technologies in the health technology market.

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단opens in new tab/window은 전 세계에서 연구와 보건 파트너십을 지원합니다.

엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원입니다. 자세한 내용은 www.elsevier.com에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.